Supplementary Figure S2 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Yinglin Song,Gui Yu,Qing Wang,Zihong Meng,Guohua Li,Yanjun Shen,Yue Wu,Peiying Li,Ming Yao,Jianren Gu,Tao Hong

DOI: https://doi.org/10.1158/0008-5472.22416647

2023-01-01

Abstract:EE does not appear to influence the expression levels of the ligands of NKG2D and CCR5 in tumors.

What problem does this paper attempt to address?

Supplementary Figure S2 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Yanfang Song,Yu Gan,Qing Wang,Zihong Meng,Guohua Li,Yuling Shen,Yufeng Wu,Peiying Li,Ming Yao,Jianren Gu,Hong Tu

DOI: https://doi.org/10.1158/0008-5472.22416647.v1

2023-01-01

Abstract:EE does not appear to influence the expression levels of the ligands of NKG2D and CCR5 in tumors.
Supplementary Figure S3 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Yinglin Song,Gui Yu,Qing Wang,Zihong Meng,Guohua Li,Yanjun Shen,Yue Wu,Peiying Li,Ming Yao,Jianren Gu,Tao Hong

DOI: https://doi.org/10.1158/0008-5472.22416644

2023-01-01

Abstract:Influence of EE on NK population in the peripheral blood and spleen of tumor-bearing mice.
Suppelmentary Figure S5 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Yinglin Song,Gui Yu,Qing Wang,Zihong Meng,Guohua Li,Yanjun Shen,Yue Wu,Peiying Li,Ming Yao,Jianren Gu,Tao Hong

DOI: https://doi.org/10.1158/0008-5472.22416656

2023-01-01

Abstract:EE increases the expression levels of INF-gamma and granzyme B in NK cells.
Supplementary Figure S6 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Yinglin Song,Gui Yu,Qing Wang,Zihong Meng,Guohua Li,Yanjun Shen,Yue Wu,Peiying Li,Ming Yao,Jianren Gu,Tao Hong

DOI: https://doi.org/10.1158/0008-5472.22416638

2023-01-01

Abstract:EE decreases serum leptin levels in wild-type and Beige mice.
Supplementary Figure S1 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Yinglin Song,Gui Yu,Qing Wang,Zihong Meng,Guohua Li,Yanjun Shen,Yue Wu,Peiying Li,Ming Yao,Jianren Gu,Tao Hong

DOI: https://doi.org/10.1158/0008-5472.22416650

2023-01-01

Abstract:Exposure to EE reduces anxiety-like behavior, decreases body weight, and increases food intake in mice.
Enriching The Housing Environment For Mice Enhances Their Nk Cell Antitumor Immunity Via Sympathetic Nerve-Dependent Regulation Of Nkg2d And Ccr5

Yanfang Song,Yu Gan,Qing Wang,Zihong Meng,Guohua Li,Yuling Shen,Yufeng Wu,Peiying Li,Ming Yao,Jianren Gu,Hong Tu

DOI: https://doi.org/10.1158/0008-5472.CAN-16-2143

IF: 11.2

2017-01-01

Cancer Research

Abstract:Mice housed in an enriched environment display a tumor-resistant phenotype due to eustress stimulation. However, the mechanisms underlying enriched environment-induced protection against cancers remain largely unexplained. In this study, we observed a significant antitumor effect induced by enriched environment in murine pancreatic cancer and lung cancer models. This effect remained intact in T/B lymphocyte-deficient Rag1-/- mice, but was nearly eliminated in natural killer (NK) cell-deficient Beige mice or in antibody-mediated NK-cell-depleted mice, suggesting a predominant role of NK cells in enriched environment- induced tumor inhibition. Exposure to enriched environ-ment enhanced NK-cell activity against tumors and promoted tumoral infiltration of NK cells. Enriched environment increased the expression levels of CCR5 and NKG2D (KLRK1) in NK cells; blocking their function effectively blunted the enriched environment-induced enhancement of tumoral infiltration and cytotoxic activity of NK cells. Moreover, blockade of b-adrenergic signaling or chemical sympathectomy abolished the effects of enriched environment on NK cells and attenuated the antitumor effect of enriched environment. Taken together, our results provide new insight into the mechanism by which eustress exerts a beneficial effect against cancer.
Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Sonia A. Patel,Monique B. Nilsson,Yan Yang,Xiuning Le,Hai T. Tran,Yasir Y. Elamin,Xiaoxing Yu,Fahao Zhang,Alissa Poteete,Xiaoyang Ren,Li Shen,Jing Wang,Seyed Javad Moghaddam,Tina Cascone,Michael Curran,Don L. Gibbons,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22494754

2023-01-01

Abstract:IL-6 modulates expression of NK receptor and their ligands in EGFR mutant tumors.
Supplementary Figure 4 from Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18

Zhiliang Ma,Wen Li,Shinichi Yoshiya,Yong Xu,Masaki Hara,Yosif El‐Darawish,Tzvetanka Markova,Kyosuke Yamanishi,Hiromichi Yamanishi,Hideaki Tahara,Yoshimasa Tanaka,Haruki Okamura

DOI: https://doi.org/10.1158/1078-0432.22459815.v1

2023-01-01

Abstract:Cytotoxic activity exhibited by PECs from pre-implanted mice receiving immune checkpoint blockade and/or IL-18
Phosphodiesterase 4A Confers Resistance to PGE2-mediated Suppression in CD25+ /CD54+ NK Cells.

Ziqing Chen,Ying Yang,Shi Y. Neo,Hao Shi,Yi Chen,Arnika K. Wagner,Karin Larsson,Le Tong,Per-Johan Jakobsson,Evren Alici,Jing Wu,Yihai Cao,Kai Wang,Lisa L. Liu,Yumeng Mao,Dhifaf Sarhan,Andreas Lundqvist

DOI: https://doi.org/10.15252/embr.202051329

IF: 9.071

2021-01-01

EMBO Reports

Abstract:Inadequate persistence of tumor-infiltrating natural killer (NK) cells is associated with poor prognosis in cancer patients. The solid tumor microenvironment is characterized by the presence of immunosuppressive factors, including prostaglandin E2 (PGE2), that limit NK cell persistence. Here, we investigate if the modulation of the cytokine environment in lung cancer with IL-2 or IL-15 renders NK cells resistant to suppression by PGE2. Analyzing Cancer Genome Atlas (TCGA) data, we found that high NK cell gene signatures correlate with significantly improved overall survival in patients with high levels of the prostaglandin E synthase (PTGES). In vitro, IL-15, in contrast to IL-2, enriches for CD25+ /CD54+ NK cells with superior mTOR activity and increased expression of the cAMP hydrolyzing enzyme phosphodiesterase 4A (PDE4A). Consequently, this distinct population of NK cells maintains their function in the presence of PGE2 and shows an increased ability to infiltrate lung adenocarcinoma tumors in vitro and in vivo. Thus, strategies to enrich CD25+ /CD54+ NK cells for adoptive cell therapy should be considered.
Supplementary Figure S10 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142141

2024-01-01

Abstract:Supplementary Figure S10. αEGFR-IFNα enhances radiation efficacy in part through CD8+ T cells
Mechanism of Enhancement of the CTL Activity in Mice Co-Expressing CD80, CD86 and CD137Lgenes

Jie Yin,Guo-Qiang Li,Yue Yu,Yi Shi,Bei-Cheng Sun,Feng Cheng,Wen-Gang Ge,Xue-Hao Wang

DOI: https://doi.org/10.3321/j.issn:0253-3766.2008.09.004

2008-01-01

Abstract:OBJECTIVE:To study the mechanism of enhancement of the CTL activity in mice co-expressing of CD80, CD86 and CD137L genes.METHODS:The mice were randomly divided into five groups, named A, B, C, D and E. The group A and B were control groups (CG). H22-BAL B/c HCC mouse model was established by subcutaneous injection with hepatocellular carcinoma cells of cell line H22-Wt (group A), H22-neo (group B), H22-CD80/CD86(+) (group C), H22-CD137L(+) (group D) and H22-CD80/CD86/CD137L(+) (group E), respectively. On the 14th, 35th, 56th and 84th day after the first inoculation of tumor cells, TUNEL staining and DNA ladder examination were used to detect apoptosis of splenic T lymphocytes in all groups at each post-inoculation time point. Electrophoretic mobility-shift assay (EMSA) method was used to detect the activity of nuclear factor kappaB (NF-kappaB) in splenic T lymphocytes in each group at each time point post-inoculation.RESULTS:Apoptosis was found in a great number of T lymphocytes in CG on the 14th day, much more than that in group C and E. The number of apoptotic T cells in group C had a significant difference compared with that in the group E from 14th to 84th day (P = 0.003). DNA ladder analysis showed typical positive results in group C and E. The significant apoptosis fragments were found in group C on 21st, 35th and 84th days. NF-kappaB activity of T cells in groups C and E was remarkably higher than that of groups CG and D, with higher in group D than that of CG (P = 0.002), and with no significant difference between group C and E on 14th day. The activity in group E was stable and remarkably higher than that of group C on 56th and 84th days after the first inoculation.CONCLUSION:H22-CD80/CD86/CD137L(+) induces higher NF-kappaB activity of the host T cells by synergistic action of CD28 and CD137, which may be one of the mechanisms of enhancement of the host CTL activity induced by co-expression of CD80, CD86 and CD137L genes.
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses

Megat Abd Hamid,Ruo-Zheng Wang,Xuan Yao,Peiwen Fan,Xi Li,Xue-Mei Chang,Yaning Feng,Stephanie Jones,David Maldonado-Perez,Craig Waugh,Clare Verrill,Alison Simmons,Vincenzo Cerundolo,Andrew McMichael,Christopher Conlon,Xiyan Wang,Yanchun Peng,Tao Dong,Ruo-zheng Wang,Xue-mei Chang

DOI: https://doi.org/10.1158/2326-6066.CIR-18-0885

IF: 10.1

2019-11-22

Cancer Immunology Research

Abstract:Immunotherapy treatments with anti-PD-1 boost recovery in less than 30% of treated cancer patients, indicating the complexity of the tumor microenvironment. Expression of HLA-E is linked to poor clinical outcomes in mice and human patients. However, the contributions to immune evasion of HLA-E, a ligand for the inhibitory CD94/NKG2A receptor, when expressed on tumors, compared with adjacent tissue and peripheral blood mononuclear cells, remains unclear. In this study, we report that epithelial-derived cancer cells, tumor macrophages, and CD141 + conventional dendritic cells (cDC) contributed to HLA-E enrichment in carcinomas. Different cancer types showed a similar pattern of enrichment. Enrichment correlated to NKG2A upregulation on CD8 + tumor-infiltrating T lymphocytes (TIL) but not on CD4 + TILs. CD94/NKG2A is exclusively expressed on PD-1 high TILs while lacking intratumoral CD103 expression. We also found that the presence of CD94/NKG2A on human tumor–specific T cells impairs IL2 receptor–dependent proliferation, which affects IFN-mediated responses and antitumor cytotoxicity. These functionalities recover following antibody-mediated blockade in vitro and ex vivo . Our results suggest that enriched HLA-E:CD94/NKG2A inhibitory interaction can impair survival of PD-1 high TILs in the tumor microenvironment.

oncology,immunology
Supplementary Figure 1 from Cancer-Induced Immunosuppression: IL-18–Elicited Immunoablative NK Cells

Magali Terme,Evelyn Ullrich,Laetitia Aymeric,Kathrin Meinhardt,Jérôme D. Coudert,Mélanie Desbois,François Ghiringhelli,Sophie Viaud,Bernard Ryffel,Hideo Yagita,Lieping Chen,Salaheddine Mécheri,Gilles Kaplanski,Armelle Prévost-Blondel,Masashi Kato,Joachim L. Schultze,Eric Tartour,Guido Kroemer,Mariapia Degli-Esposti,Nathalie Chaput,Laurence Zitvogel

DOI: https://doi.org/10.1158/0008-5472.22391028

2023-01-01

Abstract:PDF file - 87K, Kit+ CD11b- NK cells expand in lymphoid organs of mice bearing different types of tumors
Supplementary Figure S9 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142111

2024-01-01

Abstract:Supplementary Figure S9. Changes in gene expression associated with ISG + cDC2 among sequencing results
Enhanced development of functional human NK cells in NOD-scid-IL2rgnull mice expressing human IL15

Ken-Edwin Aryee,Lisa M Burzenski,Li-Chin Yao,James G Keck,Dale L Greiner,Leonard D Shultz,Michael A Brehm

DOI: https://doi.org/10.1096/fj.202200045R

Abstract:Human innate immunity plays a critical role in tumor surveillance and in immunoregulation within the tumor microenvironment. Natural killer (NK) cells are innate lymphoid cells that have opposing roles in the tumor microenvironment, including NK cell subsets that mediate tumor cell cytotoxicity and subsets with regulatory function that contribute to the tumor immune suppressive environment. The balance between effector and regulatory NK cell subsets has been studied extensively in murine models of cancer, but there is a paucity of models to study human NK cell function in tumorigenesis. Humanized mice are a powerful alternative to syngeneic mouse tumor models for the study of human immuno-oncology and have proven effective tools to test immunotherapies targeting T cells. However, human NK cell development and survival in humanized NOD-scid-IL2rgnull (NSG) mice are severely limited. To enhance NK cell development, we have developed NSG mice that constitutively expresses human Interleukin 15 (IL15), NSG-Tg(Hu-IL15). Following hematopoietic stem cell engraftment of NSG-Tg(Hu-IL15) mice, significantly higher levels of functional human CD56+ NK cells are detectable in blood and spleen, as compared to NSG mice. Hematopoietic stem cell (HSC)-engrafted NSG-Tg(Hu-IL15) mice also supported the development of human CD3+ T cells, CD20+ B cells, and CD33+ myeloid cells. Moreover, the growth kinetics of a patient-derived xenograft (PDX) melanoma were significantly delayed in HSC-engrafted NSG-Tg(Hu-IL15) mice as compared to HSC-engrafted NSG mice demonstrating that human NK cells have a key role in limiting the tumor growth. Together, these data demonstrate that HSC-engrafted NSG-Tg(Hu-IL15) mice support enhanced development of functional human NK cells, which limit the growth of PDX tumors.
Supplementary Figure S8 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142117

2024-01-01

Abstract:Supplementary Figure S8. Bulk RNA-sequencing of tumor myeloid cells 7 days after RT and αEGFR-IFNα
Supplementary Figure S2 from the E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling

Yongjing Shi,Xiaodong Zheng,Hui Peng,Chenqi Xu,Rui Sun,Zhigang Tian,Haoyu Sun,Xianwei Wang

DOI: https://doi.org/10.1158/2326-6066.27142956

2024-01-01

Abstract:Supplementary Figure S2. Tumor grown faster in cKO mice than Ncr1Cre/+ mice
Natural killer cells contribute to 'hot' tumor regression in the allergic inflammatory environment

Ying Zhou,Lin Li,Dongmei Zhou,Zhiwei Yu,Xiaohong Gu,Yaning Ren,Yuanfen Liao,Ruilin Pan,Qingqing Li,Yimin Zhu,Yubao Cui

DOI: https://doi.org/10.1016/j.intimp.2023.110760

IF: 5.714

2023-08-07

International Immunopharmacology

Abstract:Systemic immune status influences the elimination of tumor cells. However, it remains unclear how chronic inflammation in allergic diseases affects the tumor microenvironment and tumorigenesis. To investigate tumor progression in a state of heightened allergic inflammation, we established a mouse model of allergic inflammation. We used house dust mite extract to induce a hyper-reactive systemic immune response. Additionally, we subcutaneously inoculated two types of cancer cells (CT26 and 4T1 tumors). We conducted immune profiling of the ex-vivo tumor mass using multicolor flow cytometry staining and performed dynamic analysis of peripheral cytokines to explore the significant relationship between the development of allergic inflammation and tumorigenesis. We found that mice in a state of allergic inflammation were more susceptible to developing tumors. Interestingly, the growth of T cell-inflamed was inhibited in the allergic state, while growth of non-T cell-inflamed was promoted. Further research revealed that natural killer (NK) cells with enhanced tumor-killing or immune-regulating abilities were more active in " hot " tumors. Inhibiting NK cell activity can partially alleviate the impact of allergic inflammation on tumor growth. In summary, our results suggest that NK cells play significant role in suppressing tumor growth in an allergic inflammation mouse model. This phenomenon seems to be closely linked to both the inherent characteristics of the tumor and its interaction with the immune system. The innate immune system can be mobilized to synergize with the adaptive immune system to inhibit tumor growth, which opens a new way for a tumor immunotherapy.

pharmacology & pharmacy,immunology
Supplementary Figure S6 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142126

2024-01-01

Abstract:Supplementary Figure S6. Treg tumor infiltration after local RT in MC38 tumors and splenic cDC isolation strategy.
Supplementary Figure S3 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142135

2024-01-01

Abstract:Supplementary Figure S3. Changes in MC38 tumor cDC populations after local RT.

Supplementary Figure S2 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Supplementary Figure S2 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Supplementary Figure S3 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Suppelmentary Figure S5 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Supplementary Figure S6 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Supplementary Figure S1 from Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity Via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5

Enriching The Housing Environment For Mice Enhances Their Nk Cell Antitumor Immunity Via Sympathetic Nerve-Dependent Regulation Of Nkg2d And Ccr5

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Supplementary Figure 4 from Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18

Phosphodiesterase 4A Confers Resistance to PGE2-mediated Suppression in CD25+ /CD54+ NK Cells.

Supplementary Figure S10 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Mechanism of Enhancement of the CTL Activity in Mice Co-Expressing CD80, CD86 and CD137Lgenes

Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses

Supplementary Figure 1 from Cancer-Induced Immunosuppression: IL-18–Elicited Immunoablative NK Cells

Supplementary Figure S9 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Enhanced development of functional human NK cells in NOD-scid-IL2rgnull mice expressing human IL15

Supplementary Figure S8 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Figure S2 from the E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling

Natural killer cells contribute to 'hot' tumor regression in the allergic inflammatory environment

Supplementary Figure S6 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Figure S3 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance